Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




AI Algorithm Predicts Chronic Conditions from CT Scans

By HospiMedica International staff writers
Posted on 17 Dec 2018
Artificial intelligence (AI) algorithms can take advantage of existing computed tomography (CT) data to identify patients at risk of osteoporotic fractures and cardiovascular disease (CVD).

The algorithms, developed by Zebra Medical Vision (Shefayim, Israel), are based on anonymized databases of medical images and clinical data that were used to train them to discover chronic diseases by automated imaging analysis. More...
The Zebra algorithm engine can be deployed in both cloud and on-site configurations, and is designed to integrate into picture archiving and communication systems (PACS), radiological information systems (RIS), and electronic medical record (EMR) systems.

Two recent studies undertaken by Clalit Health Services (Tel Aviv, Israel), which owns and operates 1,500 primary care clinics and 14 hospitals in Israel, treating over 4 million patients, validated that the algorithms can successfully predict osteoporotic fractures and CVD. The first study involved a retrospective analysis of 48,227patients with abdominal CTs, in order to identify radiologic risk markers of major and hip-specific osteoporotic fractures. The results showed that Zebra-Med algorithms achieved equivalent risk-stratification to contemporary fracture risk assessment tool (FRAX) scoring system.

The second five-year retrospective study, which involved 14,135 patients with non-gated, unenhanced chest CT, examined the cardiovascular predictive power of the Zebra-Med automatic coronary calcium scoring (CCS) algorithm, found that it resulted in a net 4.5% increase in categorical risk-reclassification improvement. By employing the Zebra algorithms, overstretched radiology departments can increase efficiency. Both studies were presented at the 2018 Radiological Society of North America (RSNA) annual meeting, held during November 2018 in Chicago (IL, USA).

“While there are an increasing number of AI applications in imaging aiming to mimic and automate human radiologist reading, there is larger untapped potential in these imaging studies. One can use AI to extract predictive insights unavailable to date that support high-impact population health interventions to tackle chronic diseases,” said Professor Ran Balicer, MD, the head of Clalit’s Research Institute. “We are pleased with the results of these two groundbreaking research projects and are looking forward to get them into practice.”

Related Links:
Zebra Medical Vision
Clalit Health Services


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Head Rest
Medifa 61114_3
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.